TCM
REGN icon

Teza Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Teza Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-923
Closed -$485K – 256
2025
Q2 		$485K Buy
923
+527
+133% +$294K 0.36% 90
2025
Q1 		$251K Sell
396
-898
-69% -$618K 0.11% 306
2024
Q4 		$922K Buy
1,294
+429
+50% +$360K 0.14% 196
2024
Q3 		$909K Buy
+865
New +$963K 0.1% 268
2024
Q1 		– Sell
-1,643
Closed -$1.44M – 718
2023
Q4 		$1.44M Buy
+1,643
New +$1.35M 0.24% 132
2023
Q3 		– Sell
-359
Closed -$258K – 737
2023
Q2 		$258K Buy
+359
New +$277K 0.04% 439
2022
Q3 		– Sell
-351
Closed -$207K – 612
2022
Q2 		$207K Buy
+351
New +$228K 0.08% 387
2022
Q1 		– Sell
-1,529
Closed -$966K – 514
2021
Q4 		$966K Buy
1,529
+998
+188% +$614K 0.26% 119
2021
Q3 		$321K Sell
531
-4,685
-90% -$2.91M 0.15% 202
2021
Q2 		$2.91M Buy
+5,216
New +$2.64M 0.47% 54
2020
Q3 		– Sell
-1,558
Closed -$972K – 563
2020
Q2 		$972K Buy
+1,558
New +$884K 0.22% 139
2020
Q1 		– Sell
-2,809
Closed -$1.05M – 429
2019
Q4 		$1.05M Buy
2,809
+1,729
+160% +$582K 0.29% 85
2019
Q3 		$300K Buy
+1,080
New +$320K 0.08% 377
2018
Q1 		– Sell
-905
Closed -$340K – 483
2017
Q4 		$340K Buy
+905
New +$367K 0.2% 210

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Teza Capital Management's REGN Position: Q3 2025 in Review

Teza Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 923 shares — an estimated $485K sold.

Teza Capital Management first reported a position in REGN in Q4 2017 and held it in 14 quarters. The position peaked at $2.91M in Q2 2021. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Teza Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Teza Capital Management sold 923 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $485K.
  • Teza Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 14 quarters.
  • Teza Capital Management's Regeneron Pharmaceuticals position peaked at $2.91M in Q2 2021.
  • 1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Teza Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.